Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-12

Clinical Trial Update: Effects of Saxagliptin on Endothelial Function [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of saxagliptin on endothelial function in adults with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saxagliptin (saxagliptin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED